Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact
Successful treatment of disseminated Rosai-Dorfman disease with siltuximab
Hannah Lee, Gentry King, Kavita Garg, Zenggang Pan, Jennifer Tobin, William A Robinson
Haematologica March 2018 : haematol.2018.188441; doi:10.3324/haematol.2018.188441
Hannah Lee
University of Colorado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gentry King
University of Colorado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kavita Garg
University of Colorado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zenggang Pan
University of Colorado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Tobin
University of Colorado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William A Robinson
University of Colorado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Hannah Lee*,
  2. Gentry King,
  3. Kavita Garg,
  4. Zenggang Pan,
  5. Jennifer Tobin and
  6. William A Robinson
  1. University of Colorado
  1. ↵* Corresponding author; email: hannah.2.lee{at}ucdenver.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

-

  • Received January 23, 2018.
  • Accepted March 29, 2018.
  • Copyright © 2018, Ferrata Storti Foundation
PreviousNext
Back to top

Keywords

Granulocytes, Monocytes, Macrophages
cell therapy and immunotherapy
Rosai-Dorfman disease
Siltuximab

Vol 104 Issue 12

Haematologica: 104 (12)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word about Haematologica.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Successful treatment of disseminated Rosai-Dorfman disease with siltuximab
(Your Name) has forwarded a page to you from Haematologica
(Your Name) thought you would like to see this page from the Haematologica web site.
Citation Tools
Successful treatment of disseminated Rosai-Dorfman disease with siltuximab
Hannah Lee, Gentry King, Kavita Garg, Zenggang Pan, Jennifer Tobin, William A Robinson
Haematologica Mar 2018, haematol.2018.188441; DOI: 10.3324/haematol.2018.188441

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Hannah Lee, Gentry King, Kavita Garg, Zenggang Pan, Jennifer Tobin, William A Robinson
Haematologica Mar 2018, haematol.2018.188441; DOI: 10.3324/haematol.2018.188441
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Request Permissions
  • Tweet Widget
  • Facebook Like
  • Alert me when this article is cited
  • Alert me if a correction is posted

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

More in this TOC Section

Case Report

  • Kikuchi-Fujimoto disease and breast implants: is there a relationship?
  • Successful venetoclax salvage in the setting of refractory, dialysis-dependent multiple myeloma with t(11;14)
  • ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female
Show more Case Report

Cell Therapy & Immunotherapy

  • Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function
  • Management of adults and children undergoing CAR t-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
  • Association of uric acid levels before start of conditioning with mortality after alloSCT: a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Show more Cell Therapy & Immunotherapy

Related Articles

Cited By...

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online